Sano Surgery

What Sano Surgery does

Sano Surgery (DBA: Sano) is a private US telehealth company that delivers a physician-guided, 12-month GLP-1 weight management program to Hispanic/Latino adults with obesity in California and Florida. The service is operated through a dual-entity legal structure: Sano Health Management, a Florida LLC that owns and operates the technology platform, marketing, and administrative functions, and Sano Medical Group, a California professional medical corporation that provides the clinical care. Members enroll directly through the sano.healthcare website (or mobile app) via a free video consultation and pay a transparent $150/month membership fee that covers physician consultations, monthly check-ins, quarterly video visits, dose adjustments, and unlimited bilingual messaging; FDA-approved GLP-1 medications (daily pill or weekly injection) are prescribed separately and billed directly by partner pharmacies at $149–$349/month, with no insurance, prior authorization, or referral required.

The underlying platform is a conventional bilingual (English/Spanish) telehealth stack supporting video consultations, secure messaging, and remote clinical workflows, with HIPAA, CCPA/CPRA, and HITRUST CSF-aligned security controls (AES-256 at rest, TLS 1.2+ in transit, audit logging), and Stripe-based recurring billing. The go-to-market is direct-to-consumer: bilingual content marketing, patient testimonials, and educational resources targeting the documented 26% Hispanic GLP-1 prescription gap and elevated obesity/diabetes prevalence in the community. Marketing emphasizes cultural competency and family-oriented framing (por tu familia, poco a poco) and positions clinical outcomes including average ~20% body-weight loss over 72 weeks and 20–26% reduction in cardiovascular events.

Name

Sano Surgery

Legal name

Sano Medical Group

Website

https://sano.healthcare

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Sano is a private bilingual telehealth company that delivers physician-guided GLP-1 weight loss programs to Hispanic/Latino adults in California and Florida at $150/month, plus separately billed medication from partner pharmacies.

Ownership category

akta.pro rank

Product category

Telehealth Weight Management

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLALAAAD

Prescription-Based Digital Clinics (Condition-Specific Rx Programs)

Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

SECONDARYHLALAAAH

Membership/Subscription Concierge Virtual Care

Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

SECONDARYHLALAIAH

Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing

Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

SECONDARYHLAKADAL

Obesity Medicine & Weight Management

Healthcare & Life Sciences/Specialist Medical Practice/Endocrinology & Diabetes

Keywords

• Telehealth weight management
• GLP-1 medication programs
• Bilingual healthcare services
• Cash-pay obesity care
• Hispanic preventive care

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Membership Subscription: Recurring monthly membership fee of $150/month for a 12-month program covering physician consultations, monthly check-ins, quarterly video visits, dose adjustments, and unlimited messaging with the care team
2. Medication Fulfillment: Patients purchase FDA-approved GLP-1 medications (Wegovy, Zepbound, or daily pill alternatives) directly from partner pharmacies. Medication costs $149-$349/month depending on dose, paid directly to pharmacy by patients

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Sano Surgery delivers a 12-month physician-guided medical weight management program through a bilingual (English/Spanish) telehealth platform. Members enroll by booking a free video consultation and, if qualified, receive ongoing care including monthly check-ins, quarterly video visits, dose adjustments, and unlimited messaging, paired with FDA-approved GLP-1 medications (Wegovy or tirzepatide, available as daily pills or weekly injections) shipped directly from partner pharmacies. Care team services are priced at a flat $150 per month, with medication billed separately by the pharmacy at $149–$349 per month, and the program accepts no insurance.

Product overview

Sano Surgery offers a single unified product: the Sano Membership Program, a 12-month physician-guided medical weight management program. The core offering combines GLP-1 medications (available as FDA-approved daily pills or weekly injections) with telehealth clinical care delivered by a bilingual care team. Members receive an initial intake visit, monthly check-ins, quarterly video consultations, dose adjustments, and unlimited messaging. The program is cash-pay only ($150/month for care services, with medication costs of $149-$349/month additional).

Differentiator

Problem solved

Functional benefit

Products and services

• Sano Membership Program A 12-month physician-guided medical weight management program for Hispanic/Latino adults in California and Florida with BMI 30+ (or 27+ with comorbidities), priced at $150/month and providing bilingual telehealth clinical care including an initial intake, monthly check-ins, quarterly video consultations, dose adjustments, and unlimited messaging. Medication is prescribed separately and fulfilled through partner pharmacies at $149–$349/month; no insurance, referrals, or prior authorization are required.

Quantifiable outcome

• Average 20% body weight loss over 72 weeks in clinical trials with tirzepatide (individual results vary)
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Found: DTC telehealth weight management company prescribing GLP-1 medications alongside behavioral coaching. Operates a direct-to-consumer enrollment model with monthly subscription pricing parallel to Sano's offering.
• Noom Med: Noom's clinician-led GLP-1 program combines behavior change with telehealth prescription access. Targets the same patient demographic (BMI 30+ or 27+ with comorbidities) seeking physician-guided medical weight loss, with a similar subscription-plus-medication pricing model.
• Sesame: Cash-pay telehealth marketplace that lists weight management and GLP-1 prescribing services with transparent upfront pricing. Mirrors Sano's no-insurance, no-prior-authorization positioning, though with a broader marketplace model rather than a single specialty program.
• Calibrate: Metabolic health company combining clinician-led GLP-1 prescribing with a structured 12+ month lifestyle program. Closely comparable to Sano on program structure (longitudinal coaching, dose adjustments, remote care) and on target patient (BMI 27+ with comorbidities).
• PlushCare: Telehealth platform offering online physician visits and prescription services including weight management. Operates a similar licensed-physician telehealth model with subscription components and is part of the broader Accolade health ecosystem.
• Ro: Direct-to-consumer telehealth platform with a dedicated weight loss program (including GLP-1 access) and a vertically integrated pharmacy. Operates a similar cash-pay, subscription-style model to Sano across multiple therapeutic areas.
• Hims & Hers Health: Largest US direct-to-consumer telehealth platform offering prescription weight loss (GLP-1) and a wide range of other conditions. Competes with Sano for the same cash-pay, no-insurance, online-prescription patient, and is the most direct scale competitor in the space.

Emerging players

• QuickMD: Smaller telehealth provider offering weight loss consultations and prescription services including GLP-1 medications. Comparable to Sano on scale (early-stage, multi-state) and cash-pay model, though without the explicit Hispanic-specialization angle.

Broad incumbents

• WW International (WeightWatchers): Established weight management brand that has expanded into clinician-guided GLP-1 programs (WeightWatchers Clinic). Brings a large incumbent member base and brand recognition to the same condition-specific virtual care category Sano occupies.
• Teladoc Health: Large, publicly-traded telehealth incumbent offering multiple specialty virtual care services including chronic condition management. Does not target the Hispanic weight-loss niche specifically but competes broadly for the same value-based and consumer-paid telehealth mindshare.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sano-surgery

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sano Surgery